Tumor infiltrating lymphocytes in lung cancer: a new prognostic parameter

Por Reynders, Kobe, De Ruysscher, Dirk
Publicado no J Thorac Dis (2016)

Individualized hypo/hyperfractionated radiotherapy for non-small cell lung cancer

Por Chang, Joe Y., De Ruysscher, Dirk
Publicado em 2014

Focus on treatment complications and optimal management: radiation oncology

Por Billiet, Charlotte, Peeters, Stephanie, De Ruysscher, Dirk
Publicado no Transl Lung Cancer Res (2014)

Immunological metagene signatures derived from immunogenic cancer cell death associate with improved survival of patients with lung, breast or ovarian malignancies: A large-scale m...

Por Garg, Abhishek D., De Ruysscher, Dirk, Agostinis, Patrizia
Publicado no Oncoimmunology (2015)

Tumour Movement in Proton Therapy: Solutions and Remaining Questions: A Review

Por De Ruysscher, Dirk, Sterpin, Edmond, Haustermans, Karin, Depuydt, Tom
Publicado no Cancers (Basel) (2015)

Should patient set-up in lung cancer be based on the primary tumor? An analysis of tumor coverage and normal tissue dose using repeated PET/CT imaging

Por van Elmpt, Wouter, Öllers, Michel, Lambin, Philippe, De Ruysscher, Dirk
Publicado no Int J Radiat Oncol Biol Phys (2010)

Imaging techniques for tumour delineation and heterogeneity quantification of lung cancer: overview of current possibilities

Por van Elmpt, Wouter, Zegers, Catharina M.L., Das, Marco, De Ruysscher, Dirk
Publicado em 2014

The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant

Por Reynders, Kobe, Illidge, Tim, Siva, Shankar, Chang, Joe Y., De Ruysscher, Dirk
Publicado no Cancer Treat Rev (2015)

Accuracy of deformable image registration for contour propagation in adaptive lung radiotherapy

Por Hardcastle, Nicholas, van Elmpt, Wouter, De Ruysscher, Dirk, Bzdusek, Karl, Tomé, Wolfgang A
Publicado em 2013

Optimal gating compared to 3D and 4D PET reconstruction for characterization of lung tumours

Por van Elmpt, Wouter, Hamill, James, Jones, Judson, De Ruysscher, Dirk, Lambin, Philippe, Öllers, Michel
Publicado em 2011

Do We Have Enough Evidence to Implement Particle Therapy as Standard Treatment in Lung Cancer? A Systematic Literature Review

Por Pijls-Johannesma, Madelon, Grutters, Janneke P.C., Verhaegen, Frank, Lambin, Philippe, De Ruysscher, Dirk
Publicado em 2010

Response assessment using 18F-FDG PET early in the course of chemo-radiotherapy is correlated with survival in advanced stage non-small cell lung cancer

Por van Elmpt, Wouter, Öllers, Michel, Dingemans, Anne-Marie C., Lambin, Philippe, De Ruysscher, Dirk
Publicado no J Nucl Med (2012)

Multistate Statistical Modeling: A Tool to Build a Lung Cancer Microsimulation Model That Includes Parameter Uncertainty and Patient Heterogeneity

Por Bongers, Mathilda L., de Ruysscher, Dirk, Oberije, Cary, Lambin, Philippe, Uyl-de Groot, Carin A., Coupé, V. M. H.
Publicado no Med Decis Making (2015)

What is the degree of innovation routinely implemented in Dutch radiotherapy centres? A multicentre cross-sectional study

Por Jacobs, Maria, Boersma, Liesbeth, Dekker, Andre, Bosmans, Geert, van Merode, Frits, Verhaegen, Frank, de Ruysscher, Dirk, Swart, Rachelle, Kengen, Cindy, Lambin, Philippe
Publicado no Br J Radiol (2016)

Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I–III small cell lung cancer: A hypothesis generating study

Por van Loon, Judith, Offermann, Claudia, Öllers, Michel, van Elmpt, Wouter, Vegt, Erik, Rahmy, Ali, Dingemans, Anne-Marie C., Lambin, Philippe, De Ruysscher, Dirk
Publicado no Radiother Oncol (2011)

When to Wait for More Evidence? Real Options Analysis in Proton Therapy

Por Grutters, Janneke P.C., Abrams, Keith R., de Ruysscher, Dirk, Pijls-Johannesma, Madelon, Peters, Hans J.M., Beutner, Eric, Lambin, Philippe, Joore, Manuela A.
Publicado em 2011

Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?

Por Lind, Joline S. W., Meijerink, Martijn R., Dingemans, Anne-Marie C., van Kuijk, Cornelis, Öllers, Michel C., de Ruysscher, Dirk, Postmus, Pieter E., Smit, Egbert F.
Publicado em 2010

A semiautomatic CT-based ensemble segmentation of lung tumors: comparison with oncologists’ delineations and with the surgical specimen

Por Velazquez, Emmanuel Rios, Aerts, Hugo J. W. L., Gu, Yuhua, Goldgof, Dmitry B., De Ruysscher, Dirk, Dekker, Andre, Korn, René, Gillies, Robert J., Lambin, Philippe
Publicado em 2012

NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy

Por van den Heuvel, Michel M, Verheij, Marcel, Boshuizen, Rogier, Belderbos, José, Dingemans, Anne-Marie C, De Ruysscher, Dirk, Laurent, Julien, Tighe, Robert, Haanen, John, Quaratino, Sonia
Publicado no J Transl Med (2015)

Assessment of tumour size in PET/CT lung cancer studies: PET- and CT-based methods compared to pathology

Por Cheebsumon, Patsuree, Boellaard, Ronald, de Ruysscher, Dirk, van Elmpt, Wouter, van Baardwijk, Angela, Yaqub, Maqsood, Hoekstra, Otto S, Comans, Emile FI, Lammertsma, Adriaan A, van Velden, Floris HP
Publicado em 2012